Issue link: https://www.e-digitaleditions.com/i/1417310
Since becoming Inhalation’s editor 11 years ago, I have been delighted to be part of a community that focuses on collaboration, knowledge sharing, proactively meeting challenges and nurturing young talent. So I am excited to announce that, in addition to continuing as editor, I am also becoming Inhalation’s new publisher and owner! 8 OCTOBER 2021 Inhalation A LETTER FROM VICKI Since becoming Inhalation's editor 11 years ago, I have been delighted to be part of a community that focuses on collaboration, knowledge sharing, proactively meeting challenges and nurturing young talent. So I am excited to announce that, in addition to continuing as editor, I am also becoming Inhalation's new publisher and owner! e same talented, dedicated team members will join me in continuing to bring you a magazine with high- quality, peer-reviewed articles on a range of industry subjects, Back Pages on novel topics in respiratory medicine, updates from cross-industry organizations, key products and services from suppliers, and industry news. We are also returning to our longtime, simpler publishing platform, which you have told us you prefer. Our e-newsletter, Inhalation 123, now o ers more educational content and we will continue to publish our annual Reference and Buyer's Resource in January. In addition, the article archive on our website o ers free access to valuable content from 15 years of prior issues. I am grateful to the magazine's founders, Rich Cress and Kevin Clohesey, for this wonderful opportunity. It is also my sincere pleasure to thank our authors, editorial board members, additional peer reviewers, buyer's resource participants, webinar presenters and guest moderators, cross-industry and media partners, and more than 3,500 readers. We also greatly appreciate our advertisers, whose support makes it possible to bring you Inhalation. I look forward to working with all of you! Vicki L. Schuman Editor and Publisher Contact us: contact@inhalation.se or visit www.inhalation.se Inhalation Research Services The Power of Pre- Clinical Precision Can't live without the rush? Look the other way. Our Inhalation Research Services are not about taking risks, or getting adrenaline rushes. Quite the opposite. They help CROs and pharma companies to: Discover how your drug development can benefit from precision aerosol research. De-risk your clinical programs and cut costs – get in touch. De-risk clinical programs Minimize translational errors Focus on the right candidate